|
Palliative Care Delivery Systems and Integration With Palliative Care Teams
|
March 29, 2023
|
PC3I Authors Michelle Iocolano |
Seminars in Radiation Oncology
|
|
Recent advances in targeted therapies in acute myeloid leukemia
|
March 25, 2023
|
PC3I Authors Catherine Lai |
Journal of Hematology & Oncology
|
|
Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC): study protocol for the BE-EPIC randomised controlled trial
|
March 24, 2023
|
PC3I Authors Ramy Sedhom; William Ferrell; Justin Bekelman |
BMJ Open
|
|
Development and validation of a measure of adolescent and young adult goal-based quality of life (MAYA-GQOL)
|
March 23, 2023
|
PC3I Authors Lisa A. Schwartz |
Quality of Life Research
|
|
Psychosocial impact of COVID-19 on caregivers and adolescents and young adult survivors of childhood cancer
|
March 23, 2023
|
PC3I Authors Lisa A. Schwartz |
Pediatric Blood & Cancer
|
|
Insurance and racial disparities in prior authorization in gynecologic oncology
|
March 21, 2023
|
PC3I Authors Anna Jo Smith; Lakeisha Mulugeta-Gordon; Justin Bekelman; Emily Ko |
Gynecologic Oncology Reports
|
|
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90
|
March 19, 2023
|
PC3I Authors Ronac Mamtani; Melina Marmarelis |
Clinical Lung Cancer
|
|
Comment on: Premature delivery in the domestic sow in response to in utero delivery of AAV9 to fetal piglets
|
March 14, 2023
|
PC3I Authors Cara Berkowitz |
Gene Therapy
|
|
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
|
March 13, 2023
|
PC3I Authors Charu Aggarwal |
Clinical Cancer Research
|
|
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma
|
March 10, 2023
|
PC3I Authors Melina Marmarelis |
JAMA Network Open
|
|
Patient-Oriented Tools for Communicating Lung Cancer Screening Results: The First of Many Critical Components
|
March 9, 2023
|
PC3I Authors Katharine Rendle; Anil Vachani |
Chest
|
|
Oral and emotional health experience of refugees’ in the state of Massachusetts – A mixed methods approach
|
March 9, 2023
|
PC3I Authors Tamara J. Cadet |
PLoS One
|
|
Could DNA Fragments Be the Key to Early Detection of Lung Cancer?
|
March 8, 2023
|
PC3I Authors Anil Vachani |
American Journal of Respiratory and Critical Care Medicine
|
|
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
|
March 2, 2023
|
PC3I Authors Likhitha Kolla |
mSystems
|
|
Access for Cancer Caregivers to Education and Support for Shared Decision Making (ACCESS) intervention: a cluster cross-over randomised clinical trial
|
March 2, 2023
|
PC3I Authors George Demiris |
BMJ Supportive & Palliative Care
|
|
PI3king apart a rare disease with targeted therapy
|
March 2, 2023
|
PC3I Authors Haley Newman |
Blood
|
|
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
|
March 2, 2023
|
PC3I Authors Ronac Mamtani |
Journal of Cancer Research & Clinical Oncology
|
|
The Coming of Age of Nucleic Acid Vaccines during COVID-19
|
March 2, 2023
|
PC3I Authors Likhitha Kolla |
mSystems
|
|
Adjuvant Atezolizumab Should Be Administered to All Patients With Programmed Death-Ligand 1 Expressing Surgically Resected Stage II to III NSCLC After Chemotherapy: In Favor
|
February 26, 2023
|
PC3I Authors Melina Marmarelis; Charu Aggarwal |
Journal of Thoracic Oncology
|
|
A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer
|
February 25, 2023
|
PC3I Authors Melina Marmarelis |
Clinical Lung Cancer
|
